A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

PET can guide intensified salvage therapy in prostate cancer and help reduce the risk for treatment failure, new research suggests.

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

In the discussion, Petrylak highlighted advances in identifying genetic mutations and emerging strategies for early, ...

Findings show that Telomir-1 restores the body’s natural tumor suppressor defenses by reversing abnormal DNA methylation of ...

Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease.

This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...

SGMC Health now offers PLUVICTO, a cutting-edge therapy for men diagnosed with metastatic castration-resistant prostate ...

A Gaffney cancer treatment center will host free prostate cancer screenings on Thursday. Gibbs Cancer Center will be ...